Top

Published in:

01-08-2007 | Gastrointestinal

Detection of recurrent rectal cancer with CT, MRI and PET/CT

Authors: O. Schaefer, M. Langer

Published in: European Radiology | Issue 8/2007

Abstract

Computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) all have the potential to directly visualize local and distant relapse of colorectal cancer (CRC). Nevertheless, the role of diagnostic imaging for routine follow-up of CRC patients remains controversial. Although MRI and PET have advantages over CT in the detection of local recurrence, until now only a few surveillance programs recommend the use of annual CT for routine follow-up. The objective of this review is to elucidate the current status of diagnostic imaging for the detection of recurrent rectal cancer based on the recent literature and our own experience. Furthermore, an insight into contemporary surveillance programs and an outlook concerning a novel technical approach to moving-table MRI at 1.5 Tesla for staging purposes are given.

Jemal A, Siegel R, Ward E et al (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106–130PubMedCrossRef

Jessup JM, Menk HR, Fremgen A et al (1997) Diagnosing colorectal carcinoma: clinical and molecular approaches. CA Cancer J Clin 47:70–92PubMed

Arriola E, Navarro M, Pares D et al (2006) Imaging techniques contribute to increased surgical rescue of relapse in the follow-up of colorectal cancer. Dis Colon Rectum 49:478–484PubMedCrossRef

Abir F, Alva S, Longo WE et al (2006) The postoperative surveillance of patients with colon cancer and rectal cancer. Am J Surg 192:100–108PubMedCrossRef

Desch CE, Benson AB, Somerfield MR et al (2005) Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 23:8512–8519PubMedCrossRef

Kievit J (2002) Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer 38:986–999PubMedCrossRef

Abulafi AM, Williams NS (1994) Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg 81:7–19PubMedCrossRef

Titu LV, Nicholson AA, Hartley JE et al (2006) Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer. Ann Surg 243:348–352PubMedCrossRef

Miller AR (1998) Multidisciplinary management of recurrent colorectal cancer. Surg Oncol 7:209–221PubMedCrossRef

10.

Camilleri-Brennan J, Steele RJ (2001) The impact of recurrent rectal cancer on the quality of life. Eur J Surg Oncol 27:349–353PubMedCrossRef

11.

Goldberg RM, Fleming TR, Tangen CM et al (1998) Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group , and the Southwest Oncology Group. Ann Intern Med 129:27–35PubMed

12.

Huguier M, Houry S, Barrier A (2001) Local recurrence of cancer of the rectum. Am J Surg 182:437–439PubMedCrossRef

13.

Guillem JG, Chessin DB, Cohen AM et al (2005) Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 241:829–838PubMedCrossRef

14.

Longo WE, Johnson FE (2002) The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg Clin North Am 82:1091–1108PubMedCrossRef

15.

Giordano P, Efron J, Vernava AM et al (2006) Strategies of follow-up for colorectal cancer: a survey of the American Society of Colon and Rectal Surgeons. Tech Coloproctol 10:199–207PubMedCrossRef

16.

Pietra N, Sarli L, Costi R et al (1998) Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 41:1127–1133PubMedCrossRef

17.

Secco GB, Fardelli R, Gianquinto D et al (2002) Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. J Surg Oncol 28:418–423CrossRef

18.

Makela JT, Laitinen SO, Kairaluoma MI (1995) Five-year follow-up after radical surgery for colorectal cancer: results of a prospective randomized trial. Arch Surg 130:1062–1067PubMed

19.

Ohlsson B, Breland U, Ekberg H et al (1995) Follow-up after curative surgery for colorectal carcinoma: randomized comparison with no follow-up. Dis Colon Rectum 38:619–626PubMedCrossRef

20.

Kjeldsen BJ, Kronborg O, Fenger C et al (1997) A prospective randomized study of follow-up after radical surgery of colorectal cancer. Br J Surg 84:666–669PubMedCrossRef

21.

Schoemaker D, Black R, Giles L et al (1998) Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 114:7–14PubMedCrossRef

22.

Figueredo A, Rumble RB, Maroun J et al (2003) Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 3:26PubMedCrossRef

23.

Renehan AG, Egger M, Saunders MP et al (2002) Impact on survival of intensive follow-up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 324:1–8CrossRef

24.

Jeffery GM, Hickey BE, Hider P (2002) Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Library (CD002200), Oxford

25.

Chau I, Allen MJ, Cunningham D et al (2004) The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer. J Clin Oncol 22:1420–1429PubMedCrossRef

26.

Cutait R, Alves VA, Lopes LC et al (1991) Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 34:917–920PubMedCrossRef

27.

Carl J, Bentzen SM, Norgaard-Pedersen B et al (1993) Modelling of serial carcinoembryonic antigen changes in colorectal cancer. Scand J Clin Lab Invest 53:751–755PubMed

28.

ESMO Guidelines Task Force (2005) ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer. Ann Oncol 16:16–17CrossRef

29.

ESMO Guidelines Task Force (2005) ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of advanced colorectal cancer. Ann Oncol 16:18–19CrossRef

30.

ESMO Guidelines Task Force (2005) ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of rectal cancer. Ann Oncol 16:20–21CrossRef

31.

Bleeker WA, Mulder NH, Hermans J et al (2001) Value and cost of follow-up after adjuvant treatment of patients with Dukes’ C colonic cancer. Br J Surg 88:101–106PubMedCrossRef

32.

Tepper JE, O’Connell M, Niedzwiecki D et al (2002) Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control-final report of intergroup 0114. J Clin Oncol 20:1744–1750PubMedCrossRef

33.

Schaefer JF, Schlemmer H-PW (2006) Total-body MRI in oncology. Eur Radiol 16:2000–2015PubMedCrossRef

34.

Stueckle CA, Haegele KF, Jendreck M et al (2005) Improvements in detection of rectal cancer recurrence by multiplanar reconstruction. Radiologe 45:930–935CrossRef

35.

Stueckle CA, Adams S, Stueckle KF et al (2006) Multi-detector CT in the evaluation of patients with recurrence of rectal cancer. Technol Cancer Res Treat 5:285–289PubMed

36.

Blomqvist L, Holm T, Goranson H et al (1996) MR imaging, CT and CEA scintigraphy in diagnosis of local recurrence of rectal cancer. Acta Radiol 37:779–784PubMedCrossRef

37.

Pema PJ, Bennett WF, Bova JG et al (1994) CT vs MRI in diagnosis of recurrent rectosigmoid carcinoma. J Comp Assist Tomogr 18:256–261CrossRef

38.

Castells A, Bessa X, Daniels M et al (1998) Value of postoperative surveillance after radical surgery for colorectal cancer. Dis Colon Rectum 41:714–724PubMedCrossRef

39.

Deveney KE, Way LW (1984) Follow-up of patients with colorectal cancer. Am J Surg 148:717–722PubMedCrossRef

40.

Stoker J, Rociu E, Wiersma TG et al (2000) Imaging of anorectal disease. Br J Surg 87:10–27PubMedCrossRef

41.

Markus J, Morrissey B, deGara C et al (1997) MRI of recurrent rectosigmoid carcinoma. Abdom Imaging 22:338–342PubMedCrossRef

42.

Torricelli P, Pecchi A, Luppi G et al (2003) Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer. Abdom Imaging 28:19–27PubMedCrossRef

43.

Dicle O, Obuz F, Cakmakci H (1999) Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging. Br J Radiol 72:1155–1159PubMed

44.

Akhurst T, Larson SM (1999) Positron emission tomography imaging of colorectal cancer. Semin Oncol 26:577–583PubMed

45.

Fukunaga H, Sekimoto M, Ikeda M et al (2004) Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer. Ann Surg Oncol 12:1–9

46.

Huebner RH, Park KC, Shepherd JE et al (2000) A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41:1177–1189PubMed

47.

Gearhart SL, Frassica D, Rosen R et al (2005) Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol 13:397–404CrossRef

48.

Moore HG, Akhurst T, Larson SM et al (2003) A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 197:22–28PubMedCrossRef

49.

Even-Sapir E, Parag Y, Lerman H et al (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 232:815–822PubMedCrossRef

50.

von Schulthess GK, Steinert HC, Hany TF (2006) Integrated PET/CT: current applications and future directions. Radiology 238:405–422CrossRef

51.

Kamel IR, Cohade C, Neyman E et al (2004) Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdom Imaging 29:663–668PubMedCrossRef

52.

Bhattacharjya S, Bhattacharjya T, Baber S et al (2004) Prospective study of contrast-enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging of colorectal liver metastases for liver resection. Br J Surg 91:1361–1369PubMedCrossRef

53.

Kinkel K, Lu Y, Both M et al (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224:748–756PubMedCrossRef

54.

Bipat S, van Leeuwen MS, Comans EFI et al (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis—meta-analysis. Radiology 237:123–131PubMedCrossRef

55.

Schmidt GP, Baur-Melnyk A, Herzog P et al (2005) High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 40:743–753PubMedCrossRef

56.

MERCURY Study Group (2006) Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ, DOI 10.1136/bmj.3897.646400.55

57.

Bipat S, Glas AS, Slors FJM et al (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology 232:773–783PubMedCrossRef

58.

Klessen C, Rogalla P, Taupitz M (2006) Local staging of rectal cancer: the current role of MRI. Eur Radiol 17:379–389PubMedCrossRef

59.

Brown G (2005) Thin section MRI in multidisciplinary pre-operative descision making for patients with rectal cancer. Br J Radiol 78:117–127CrossRef

60.

Kim CK, Kim SH, Chun HK et al (2006) Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging. Eur Radiol 16:972–980PubMedCrossRef

61.

Torkzad MR, Hansson KA, Lindholm J et al (2006) Significance of mesorectal volume in staging of rectal cancer with magnetic resonance imaging and the assessment of involvement of the mesorectal fascia. Eur Radiol [Epub ahead of print]

62.

Torkzad MR, Blomqvist L (2005) The mesorectum: morphometric assessment with magnetic resonance imaging. Eur Radiol 15:1184–1191PubMedCrossRef

63.

Fautz H-P, Kannengiesser SAR (2006) Sliding multislice (SMS): a new technique for minimum FOV usage in axial continously moving-table acquisitions. Magn Reson Med 55:363–370PubMedCrossRef

64.

Ludwig U, Sommer G, Zaitsev M et al (2006) 2D axial moving table acquisitions with dynamic slice adaption. Magn Reson Med 55:423–430PubMedCrossRef

65.

Sommer G, Fautz H-P, Ludwig U et al (2006) Multicontrast sequences with continuous table motion: a novel acquisition technique for extended field of view imaging. Magn Reson Med 55:918–922PubMedCrossRef

66.

Chassin MR, Galwin RW (1998) The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health care Quality. JAMA 280:1000–1005PubMedCrossRef

Title: Detection of recurrent rectal cancer with CT, MRI and PET/CT
Authors: O. Schaefer
M. Langer
Publication date: 01-08-2007
Publisher: Springer-Verlag
Published in: European Radiology / Issue 8/2007
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-007-0613-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Detection of recurrent rectal cancer with CT, MRI and PET/CT

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2007

Measurement by multidetector CT scan of the volume of hypopharyngeal and laryngeal tumours: accuracy and reproducibility

Microbubble ultrasound contrast agents: an update

Computed tomography pulmonary embolism index for the assessment of survival in patients with pulmonary embolism

Actual role of radiofrequency ablation of liver metastases

Self-expanding nitinol stents for treatment of infragenicular arteries following unsuccessful balloon angioplasty

Staging of carcinoma of the uterine cervix and endometrium